Glaucoma News

SEATTLE — Glaucoma patients tend to overestimate their level of adherence to medical therapy, according to a study comparing self-reported medication adherence scores with electronic health record, or EHR, system data.

SEATTLE — ChatGPT did not recognize several common symptoms of congenital glaucoma and did not recommend urgent evaluation by a pediatric eye care specialist, according to a poster presentation.

Qlaris Bio raised $24 million during series B financing for the clinical development of QLS-111, a new IOP-lowering drug candidate for patients with glaucoma, the company announced in a press release.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Mengyu Wang, PhD, discusses vision and language modeling for better glaucoma screening.

The AI-based software startup company iHealthScreen has been awarded a U.S. patent for its iPredict glaucoma detection system, the company announced in a press release.

Sight Sciences received a positive jury trial verdict of $34 million in a patent infringement case against Alcon and its Hydrus microstent, according to a press release.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Kin Sheng Lim, MD, discusses a randomized controlled trial on endoscopic cyclophotocoagulation, or ECP, for primary open-angle glaucoma.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Richard A. Lewis, MD, chief medical officer of ViaLase, provides an update on femtosecond laser image-guided high-precision trabeculotomy for the treatment of glaucoma.

BOSTON — A sustained-release bimatoprost drug delivery platform shows promise in the treatment of ocular hypertension and open-angle glaucoma, according to a poster at the American Society of Cataract and Refractive Surgery meeting.

BOSTON — In this Healio Video Perspective from Eyecelerator@ASCRS, Matt Link, chief commercial officer of Sight Sciences, shares information on the company’s clinical trials.